COLL vs NVS
Collegium Pharmaceutical Inc (COLL) versus NVS (NVS) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
NVS (NVS) common stock.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
NVS does not have a complete income-statement cache yet.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. NVS currently screens at market cap $0.
Not investment advice. Open the COLL and NVS stock pages for the full models.
Not investment advice.